Skip to main content

Table 1 Characteristics of PCOS patients vs controls

From: Involvement of impaired CD8+ mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome

  PCOS patients Controls P-value
Age, (year) 28.10±9.11 29.25±4.11 0.9897
BMI, (kg/m2) 26.26±4.29 24.93±4.15 0.1207
FSH, (IU/L) 6.46±1.70 7.08±1.90 0.0848
LH, (IU/L) 12.43±9.60 6.37±2.10 0.0002
LH/FSH 2.28±3.04 0.94±0.38 0.0073
E2, (pmol/L) 139.1±76.27 154.4±65.23 0.2907
T (nmol/L) 6.95±14.42 1.26±0.54 0.0142
PRL, (ng/ml) 22.31±49.28 16.41±8.36 0.4552
FPG, (mmol/L) 5.62±1.23 5.39±0.56 0.2716
2h PG, (mmol/L) 6.92±2.00 6.80±0.64 0.7088
FINS, (pmol/L) 16.70±14.0 12.75±6.54 0.0975
2h INS, (pmol/L) 52.40±40.50 39.55±17.92 0.0607
HOMA-IR 4.35±3.81 3.10±1.77 0.0547
  1. This table represented the clinical and biochemical characteristics of PCOS patients (n =68) and controls (n =40). All values were expressed as mean±SD. P-values were calculated by using an unpaired Student's t-test. BMI body mass index, FSH follicular stimulating hormone, LH luteinizing hormone, E2 estradiol, T testosterone, PRL prolactin, FPG fasting plasma glucose, 2h PG 2hour plasma glucose, FINS fasting insulin, 2h INS 2hour insulin, HOMA-IR homeostasis model assessment of insulin resistance